Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.

Peggs KS, Quezada SA, Korman AJ, Allison JP.

Curr Opin Immunol. 2006 Apr;18(2):206-13. Epub 2006 Feb 7. Review.

PMID:
16464564
[PubMed - indexed for MEDLINE]
2.

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.

Maker AV, Attia P, Rosenberg SA.

J Immunol. 2005 Dec 1;175(11):7746-54.

PMID:
16301685
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T, Sakaguchi S.

J Exp Med. 2005 Oct 3;202(7):885-91. Epub 2005 Sep 26. Erratum in: J Exp Med. 2012 Feb 13;209(2):423.

PMID:
16186187
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.

Ghiringhelli F, Puig PE, Roux S, Parcellier A, Schmitt E, Solary E, Kroemer G, Martin F, Chauffert B, Zitvogel L.

J Exp Med. 2005 Oct 3;202(7):919-29. Epub 2005 Sep 26.

PMID:
16186184
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA.

J Clin Oncol. 2005 Sep 1;23(25):6043-53. Epub 2005 Aug 8.

PMID:
16087944
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies.

Korman A, Yellin M, Keler T.

Curr Opin Investig Drugs. 2005 Jun;6(6):582-91. Review.

PMID:
15988909
[PubMed - indexed for MEDLINE]
7.

Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW.

J Exp Med. 2005 Apr 4;201(7):1037-44.

PMID:
15809349
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

Sakaguchi S.

Nat Immunol. 2005 Apr;6(4):345-52. Review.

PMID:
15785760
[PubMed - indexed for MEDLINE]
9.

The B7 family revisited.

Greenwald RJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2005;23:515-48. Review.

PMID:
15771580
[PubMed - indexed for MEDLINE]
10.

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.

Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX.

J Exp Med. 2005 Mar 7;201(5):779-91.

PMID:
15753211
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4.

Kataoka H, Takahashi S, Takase K, Yamasaki S, Yokosuka T, Koike T, Saito T.

Int Immunol. 2005 Apr;17(4):421-7. Epub 2005 Feb 21.

PMID:
15724061
[PubMed - indexed for MEDLINE]
Free Article
12.

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, Khazaie K.

Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):419-24. Epub 2004 Dec 27.

PMID:
15623559
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.

Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA.

Eur J Immunol. 2004 Nov;34(11):2996-3005.

PMID:
15468055
[PubMed - indexed for MEDLINE]
14.

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W.

Nat Med. 2004 Sep;10(9):942-9. Epub 2004 Aug 22.

PMID:
15322536
[PubMed - indexed for MEDLINE]
Free Article
15.

Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.

Ribas A, Glaspy JA, Lee Y, Dissette VB, Seja E, Vu HT, Tchekmedyian NS, Oseguera D, Comin-Anduix B, Wargo JA, Amarnani SN, McBride WH, Economou JS, Butterfield LH.

J Immunother. 2004 Sep-Oct;27(5):354-67.

PMID:
15314544
[PubMed - indexed for MEDLINE]
16.

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.

Viguier M, LemaƮtre F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L.

J Immunol. 2004 Jul 15;173(2):1444-53.

PMID:
15240741
[PubMed - indexed for MEDLINE]
Free Article
17.

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Sakaguchi S.

Annu Rev Immunol. 2004;22:531-62. Review.

PMID:
15032588
[PubMed - indexed for MEDLINE]
18.

Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.

Dittmer U, He H, Messer RJ, Schimmer S, Olbrich AR, Ohlen C, Greenberg PD, Stromnes IM, Iwashiro M, Sakaguchi S, Evans LH, Peterson KE, Yang G, Hasenkrug KJ.

Immunity. 2004 Mar;20(3):293-303. Erratum in: Immunity. 2004 May;20(5):653.

PMID:
15030773
[PubMed - indexed for MEDLINE]
Free Article
19.

Activation requirements for the induction of CD4+CD25+ T cell suppressor function.

Thornton AM, Piccirillo CA, Shevach EM.

Eur J Immunol. 2004 Feb;34(2):366-76.

PMID:
14768041
[PubMed - indexed for MEDLINE]
20.

Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques.

Keler T, Halk E, Vitale L, O'Neill T, Blanset D, Lee S, Srinivasan M, Graziano RF, Davis T, Lonberg N, Korman A.

J Immunol. 2003 Dec 1;171(11):6251-9.

PMID:
14634142
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk